Technology
Overview
BioSense develops and translates advanced photonic and optoacoustic sensing technologies toward clinically relevant and deployable biomedical applications.
Our technology builds on strong scientific foundations while focusing on system integration, robustness, and relevance for real-world medical environments.
Photonic and optoacoustic sensing
BioSense technologies are based on advanced biophotonic and optoacoustic sensing principles, enabling depth-resolved and label-free interrogation of biological tissue.
By combining optical excitation with acoustic detection, optoacoustic approaches provide access to functional and structural information that is difficult to obtain with purely optical or surface-weighted methods.
Multimodal signal acquisition and data analytics
BioSense develops integrated approaches for multimodal signal acquisition, electronics, and data analytics, enabling robust extraction of clinically meaningful features from complex biomedical signals. Emphasis is placed on reproducibility, noise rejection, and quantitative performance, supporting translation from laboratory demonstrations toward relevant environments.
System integration and miniaturization
A key focus of BioSense is the integration and miniaturization of advanced sensing technologies toward compact, portable, and scalable configurations. This includes optical and acoustic subsystem integration, dedicated electronics, thermal and mechanical stability considerations, and system-level optimization for usability and deployment beyond laboratory settings.
Translation toward medical devices
BioSense frames its translational work downstream clinical use in mind, supporting the maturation of research-grade technologies toward non-invasive and regulatory-aware biomedical applications.
Early consideration is given to clinical workflows, usability, safety, and exploitation pathways, reducing downstream risk and supporting progression toward clinical validation.
Regulatory awareness, medical device standards considerations, and alignment with MDR and CE-marking requirements are considered early in the translational process, supporting future clinical validation pathways.
Technology disclosure and scope
Detailed technical specifications, performance metrics, and application-specific implementations are developed and disclosed in appropriate project, collaboration, or regulatory contexts. The information presented here reflects the underlying technological principles and translation approach, rather than product-specific claims.